- Home
- CELH vs FMS Comparison
CELH vs FMS Comparison
Compare CELH & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELH | FMS |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Misc Health and Biotechnology Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 14.2B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | CELH | FMS |
|---|---|---|
| Price | $35.23 | $23.43 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 17 | 2 |
| Target Price | ★ $64.81 | $30.00 |
| AVG Volume (30 Days) | ★ 6.6M | 428.3K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $1,318,014,000.00 | N/A |
| Revenue This Year | $37.04 | N/A |
| Revenue Next Year | $9.89 | $3.83 |
| P/E Ratio | $139.42 | ★ $15.62 |
| Revenue Growth | ★ 101.65 | N/A |
| 52 Week Low | $32.36 | $20.96 |
| 52 Week High | $66.74 | $30.46 |
Technical Indicators
Market Signals| Indicator | CELH | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 41.34 | 57.04 |
| Support Level | $33.09 | $23.38 |
| Resistance Level | $37.40 | $24.02 |
| Average True Range (ATR) | 1.57 | 0.37 |
| MACD | 0.40 | 0.08 |
| Stochastic Oscillator | 49.88 | 79.63 |
Price Performance
Historical ComparisonAbout CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.